Galenica Ltd.

GALE

Equity

ISIN CH0360674466 / Valor 36067446

SIX Swiss Exchange (2024-11-21)

CHF 75.85+0.40%

Galenica Ltd.
UMushroom community rating:

0.00 0 votes No rating yet

NegativeNeutralPositive

About company

Galenica Ltd. is a Swiss company that operates Health Supply Ltd., focusing on improving the transportation of medicines and healthcare products to providers. The company aims to enhance efficiency and sustainability in the Swiss healthcare market by meeting the needs of patients and customers through a seamless and personalized approach. Galenica operates a network of over 20 Business Units, collaborating with key partners in the Swiss healthcare industry to achieve its goals.

Summarized from source with an LLMView SourceSector: Healthcare

Revenue Growth

In the financial year 2023, Galenica Ltd. reported a 4.4% increase in sales, reaching CHF 3,746.0 million. This growth was achieved despite the absence of extraordinary sales related to COVID-19 from the previous year.

Adjusted EBIT

Galenica Ltd.'s adjusted EBIT for 2023 saw a slight increase of 0.4%, amounting to CHF 191.3 million. When adjusted for special effects totaling CHF 9.8 million, the adjusted EBIT would have increased by 5.5% to CHF 201.1 million.

Dividend

For the financial year 2023, Galenica Ltd. announced a dividend of CHF 2.20 per share, reflecting the company's commitment to returning value to its shareholders.

Net Sales

Galenica Ltd. achieved consolidated net sales of CHF 3,746.0 million in 2023, marking a significant milestone in the company's financial performance for the year.

Outlook

Galenica Ltd. continues to focus on strengthening its market position and developing its core competencies, aiming for sustainable and successful growth in the healthcare market.

Summarized from source with an LLMView Source

Key figures

7.13%1Y

14.1%3Y

26.7%5Y

Performance

13.5%1Y

17.6%3Y

18.8%5Y

Volatility